Results 91 to 100 of about 27,935 (169)

Cryptococcal Osteomyelitis in a Virally Suppressed Adolescent Living With HIV: A Case Report. [PDF]

Case Rep Infect Dis
Mandikiyana Chirimuta LA, Rambanapasi C, Musorowegomo D, Nyatanga G, Mapfumo A, Chikati EF.   +5 more
europepmc   +1 more source

Fisetin as an Antiviral Agent Targeting the RNA-Dependent RNA Polymerase of SARS-CoV-2: Computational Prediction and In Vitro Experimental Validation. [PDF]

Microorganisms
Hernández-Rodríguez X, Lira-Hernández FI, Reyes-Ruíz JM, Osuna-Ramos JF, Farfán-Morales CN, Calderón-Sandate DN, Castañeda-Delgado JE, León-Juárez M, Ángel RMD, Rivas-Santiago B, Noriega S, Cañedo-Figueroa DM, Montaño S, Santos-Mena AO, García-Herrera AC, De Jesús-González LA.   +15 more
europepmc   +1 more source

Central auditory tests reveal deficits in HIV treatment. [PDF]

Front Public Health
Kambhampaty AK, Niemczak CE, Hill RA, Howe CG, Leigh SM, Lichtenstein J, Roth RM, Adhikari M, Zhang L, Fellows AM, Magohe A, Palumbo P, Gui J, Massawe ER, Buckey JC.   +14 more
europepmc   +1 more source

Phenotypic impacts of treatment-selected mutations in HIV-2 protease on darunavir and lopinavir susceptibility: Evaluating genotypic HIV-2 drug resistance tools. [PDF]

PLOS Glob Public Health
Raugi DN, Nixon RS, Smith RA, Hawes SE, Diallo K, Diallo MB, Faye K, Diaw B, Sy MP, Sall F, Seydi M, Gottlieb GS, University of Washington-Senegal HIV-2 Study Group.   +12 more
europepmc   +1 more source

Advancements in development of novel class of HIV protease inhibitors. [PDF]

Ann Med
Gu WG, Yin GZ, Zhang YP.
europepmc   +1 more source

Pharmacokinetics of lopinavir/ritonavir in second-line treatment of children with HIV in the CHAPAS-4 trial. [PDF]

AIDS
Kamphuis AEM, Kiezebrink T, Waalewijn H, Bamford A, Szubert AJ, Chabala C, Bwakura-Dangarembizi M, Makumbi S, Nangiya J, Mumbiro V, Mulenga V, Musiime V, de Wildt SN, Colbers APH, Gibb DM, Burger DM, CHAPAS-4 trial team.   +16 more
europepmc   +1 more source

Pharmacokinetic Simulation of Optimal Lopinavir and Ritonavir Dose Combination for COVID-19: Boosting Lopinavir With Ritonavir. [PDF]

In Vivo
Nakamaru Y, Sako KI, Ide N, Matsuda Y, Yamashita F, Maeda T.   +5 more
europepmc   +1 more source

Cartilage-protective effects of lopinavir/ritonavir: in vitro and in silico exploration of the HIF-1α/SOX9/IL-1β pathway. [PDF]

J Orthop Surg Res
Ozbek H, Yilmaz I, Akyuz A, Pehlivanoglu S, Sirin DY, Albayrak M, Yilmaz OF.   +6 more
europepmc   +1 more source

Lipid profile dynamics and associated cardiovascular disease risk indices in Chinese people living with human immunodeficiency virus receiving antiretroviral therapy. [PDF]

BMC Infect Dis
Qiu L, Fang C, Chen F, Hu T, Tong X, Tu Z, Li Z, Wang L, Qi X, Yi L, Liu M, Zhang Z, Lu L.   +12 more
europepmc   +1 more source

Persistent Seronegativity and Absence of Intact Proviruses Despite Prolonged Initial Viremia in Early-Treated Perinatal HIV Infection. [PDF]

Open Forum Infect Dis
Charre C, Buseyne F, Mélard A, Gardiennet E, Mariaggi AA, Montange T, Le Chenadec J, Warszawski J, Blanche S, Avettand-Fenoël V, Frange P.   +10 more
europepmc   +1 more source